A Professional Networking Site for Doctors & Medical Students Worldwide

Therapeutics, Products & Prescriptions (India)

Information

Specially addressed to the fresh graduates, this group seeks to address the difficulties they face while writing prescriptions in the OPD, emergency or wards.

Just theoretical knowledge proves inadequate if we do not know the common products available in the market and their composition etc. This is even more important when one struggles to recollect the dosage in mg/kg to be able to guide the nurses when the phial/ vial mentions the strength of an injection in just %, mg% or gm% &/ or when the ampoule has to be added to infusion fluid in the IV drip/ administered intra-muscularly.

Location: Delhi (India)
Members: 59
Latest Activity: Jan 28, 2016

Discussion Forum

cns depressants 1 Reply

ppt on cns depressantsContinue

Started by sindujhaa. Last reply by G Singh Oct 16, 2013.

View All

Comment Wall

Comment

You need to be a member of Therapeutics, Products & Prescriptions (India) to add comments!

Comment by G Singh on September 8, 2014 at 11:15pm: Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma:

http://www.nejm.org/doi/full/10.1056/NEJMoa1403291?query=OF

Comment by G Singh on September 5, 2014 at 11:09pm: Combination of voriconazole and caspofungin for complicated fungal infections:

http://en.wikipedia.org/wiki/Voriconazole

Comment by G Singh on August 20, 2014 at 11:18pm: COPD patients with CHF or CAD using BB suffer fewer exacerbations and visits to the ER:

http://www.mdlinx.com/pulmonology/template_cms.cfm?rec_rep=&int...

Comment by G Singh on July 16, 2014 at 11:51pm

Ulipristal is a Selective Progesterone Receptor Modulator (SPRM) which can be used as emergency contraceptive for upto 120 hours after unprotected intercourse i.e. 2 days more than the conventional emergency contraceptive levonorgestrel. Dosage: 30 mg. Side Effects include menstrual delay and sometimes ovarian cyst formation. Effectiveness is comparable to levonorgestrel, failure rate being 1-3%.
Personalized Gene Therapy for Retinitis Pigmentosa: Columbia University Medical Center (CUMC) researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa (RP), a leading cause of vision loss. The approach, the first of its kind, takes advantage of induced pluripotent stem (iPS) cell technology to transform skin cells into retinal cells, which are then used as a patient-specific model for disease study and preclinical testing. (brightsurf.com, 10.7.2014)
Eating more fruits and vegetables for Weight Loss? A new study from researchers at the University of Alabama at Birmingham claims that a common weight-loss tactic of increasing the feeling of being full by eating more fruits and vegetables is not an effective diet recommendation. (Medicalnewstoday)
Decrease in Life Expectancy due to Extreme Obesity: Compared with having a normal weight, persons having a BMI between 40 and 59 kg/m2 (Class 3 or Extreme Obesity) results in an estimated loss of 6.5-13.7 years of life, and mortality rates rose to more than 2.5 times according to a 30-year study (National Cancer Institute Cohort Consortium Study in the US, Sweden and Australia).
Watching 3 or more hours of television each day doubled the risk of early death from all causes, compared with participants who reported watching 1 hour or less of television a day (A study by the Department of Public Health at the University of Navarra in Spain, published in JAHA)
Team approaches using nurse-managed protocols help improve health outcomes among patients with chronic diseases (moderately severe diabetes, hypertension, and hyperlipidemia), according to a meta-analysis of studies involving more than 23,000 patients. (Ann. Intern. Med. 2014 July 14)
Benefits of Fasting in Weight Control: After 10-12 hours of fasting, the body starts pulling LDL Cholesterol out of fat cells and uses it as energy, as per the researchers at Intermountain Medical Centre at Murray, Utah who will be presenting their results in ADA Scientific Session on July 14, 2014.
FDA Approval for Inhaled Insulin: FDA has approved use of inhaled insulin, Alfrezza. It is a rapid acting insulin which is absorbed through lung cells into the blood stream where the peak levels are achieved in 15-20 minutes.

Comment by G Singh on July 2, 2014 at 9:36pm: Ribavirin is the only treatment for human metapneumovirus. (mdlinx)

Comment by G Singh on July 2, 2014 at 9:04pm: The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing of a once-daily combination of the antivirals dolutegravir, abacavir, and lamivudine (Triumeq, ViiV Healthcare UK) for the treatment of HIV infection in adults and adolescents older than 12 years of age weighing at least 40 kg.

The recommendation is for Triumeq in 50-, 300-, and 600-mg film-coated tablets containing the integrase inhibitor dolutegravir and the nucleoside analogues abacavir and lamivudine.

(Medscape)

Comment by G Singh on July 2, 2014 at 9:02pm: The US Food and Drug Administration (FDA) has approved the inhaled human insulin product Afrezza (MannKind) to improve glycemic control in adults with type 1 and type 2 diabetes. (Medscape)

Comment by G Singh on June 25, 2014 at 7:16pm: Patients with schizophrenia on once–monthly aripiprazole experienced a significant lower rates of psychiatric hospitalizations compared with the oral antipsychotics (American Society of Clinical Psychopharmacology (ASCP) 2014)

Comment by G Singh on June 25, 2014 at 7:09pm: 24–hour transdermal rotigotine (RTG) patch for patients with restless legs syndrome (RLS) who have not responded to other treatments (18th International Congress of Parkinson’s Disease and Movement Disorders in Stockholm.)